A prospective randomised controlled trial assessing the efficacy of Pegatanib sodium (Macugen®) in the prevention of proliferative diabetic retinopathy
Phase 4
Completed
- Conditions
- Topic: EyeSubtopic: Eye (all Subtopics)Disease: OphthalmologyEye DiseasesProliferative diabetic retinopathy
- Registration Number
- ISRCTN27864936
- Lead Sponsor
- Frimley Park Hospital NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Not provided at time of registration
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method